8-K

Company

Compass Therapeutics, Inc.

Filed

June 30, 2021

Period of Report

June 25, 2021

Accession Number

0000950170-21-000411

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →